Fractyl Health Q4 GAAP EPS $(11.18) Down From $(7.39) YoY, Sales $7.00K
Portfolio Pulse from Benzinga Newsdesk
Fractyl Health reported a Q4 GAAP EPS of $(11.18), a decrease from $(7.39) year-over-year. Sales were reported at $7.00K.
April 01, 2024 | 11:23 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Fractyl Health, mentioned in the article, reported a decrease in Q4 GAAP EPS to $(11.18) from $(7.39) YoY, with sales at $7.00K.
The significant drop in GAAP EPS from $(7.39) to $(11.18) YoY, alongside the low sales figure of $7.00K, suggests a negative short-term impact on Fractyl Health's financial health and potentially its stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100